Yet, with most vaccines focusing on the viral spike protein (S protein), the advent of the SARS-CoV-2 Omicron variant, characterized by up to 32 mutations in the S protein’s neutralizing antibody target sites, has jeopardized the effectiveness of current vaccines against COVID-19 [3]. Here, PROS1 is linked to COVID-19.